Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Cytokinetics is a US-based biopharmaceutical company dedicated to discovering and developing innovative medicines for patients with muscle function disorders. The company focuses on cardiovascular diseases, including hypertrophic cardiomyopathy and dilated cardiomyopathy, as well as skeletal muscle diseases. Cytokinetics aims to create groundbreaking therapies to significantly improve the quality of life for these patients.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Cytokinetics is scheduled to report its next quarterly earnings on 10/29/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Cytokinetics last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -1.50 USD.
Across its last 3 earnings reports, Cytokinetics stock moved by ±5% on average the following day. The largest reaction was -10.3% on 02/24/2026; 1 of 3 reactions were positive.
Cytokinetics has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.